Morphosis Capital Fund I Cooperatief UA reports a significant increase in turnover and EBITDA for its portfolio companies in 2023, marking successful growth and expansion in the health and wellness sector in Romania.

Target Information

Morphosis Capital Fund I Cooperatief UA is a growth capital fund that achieved a combined turnover of EUR 100 million in 2023 from its portfolio companies, marking a 49% increase compared to 2022. This impressive growth is accompanied by a 52% rise in EBITDA for the portfolio in the same year. The fund currently includes several entrepreneurial enterprises such as DocProcess, Medima Health, EMI, Cronos Med, and Stay Fit Gym, and in 2023, it successfully completed its first full exit by divesting its minority stake in Dr. Leahu Dental Clinics.

Industry Overview

Within Romania, the health and wellness sector is experiencing significant growth, driven by increasing demand for quality healthcare services. The portfolio companies of Morphosis Capital, particularly those in healthcare, are capitalizing on this trend by expanding their operations and enhancing service accessibility across the country. Companies like Medima Health and Cronos Med are introducing innovative solutions that target unmet health needs, reflecting a growing recognition of health and wellness as vital components of overall well-being.

The Romanian market for health services is characterized by a fragmented landscape, creating opportunities for companies to differentiate themselves and capture market share. With limited competition from local players, Morphos